BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36278969)

  • 1. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
    Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
    Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
    Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
    He L
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.
    Demortier J; Vautier M; Chosidow O; Gallay L; Bessis D; Berezne A; Cordel N; Schmidt J; Smail A; Duffau P; Jachiet M; Begon E; Gottlieb J; Chasset F; Graveleau J; Marque M; Cesbron E; Forestier A; Josse S; Kluger N; Beauchêne C; Le Corre Y; Pagis V; Rigolet A; Guillaume-Jugnot P; Authier FJ; Guilain N; Streichenberger N; Leonard-Louis S; Boussouar S; Landon-Cardinal O; Benveniste O; Allenbach Y
    Rheumatology (Oxford); 2023 Dec; 62(12):3932-3939. PubMed ID: 37010495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
    Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
    Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
    Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
    Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile dermatomyositis: a tertiary center experience.
    Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
    Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse Gottron papules in juvenile dermatomyositis: an under recognized clinical entity.
    Jindal AK; Guleria S; Pilania RK; Bishnoi A; Vinay K; Dogra S; Suri D; Rawat A; Singh S
    Rheumatol Int; 2018 Jun; 38(6):1153-1160. PubMed ID: 29721695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
    Walling HW; Gerami P; Sontheimer RD
    Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
    [No Abstract]   [Full Text] [Related]  

  • 14. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
    Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
    Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
    Vuppala A; Sondhi M; Umer S
    Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
    Fujisaki M; Kasamatsu H; Nishimura K; Yoshida Y; Muneishi Y; Yamaguchi T; Nishino I; Konishi R; Ichimura Y; Okiyama N; Oyama N; Hasegawa M
    J Dermatol; 2024 Feb; 51(2):301-306. PubMed ID: 37830399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody Profile of Children with Juvenile Dermatomyositis.
    Sharma A; Bhattarai D; Gupta A; Guleria S; Rawat A; Vignesh P; Garg R; Singh S
    Indian J Pediatr; 2021 Dec; 88(12):1170-1173. PubMed ID: 33694062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in dermatomyositis-specific autoantibodies.
    Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
    Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.